51 results
Page 2 of 3
20-F/A
26l1 9gpq9
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
ttp5u4 ue3c4
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
4r8g cpvh7
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
lf5jkh0i2v h9
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.1
vc0 uu56m
14 Jan 15
BioLineRx Announces Completion of Enrollment in CE
12:00am
6-K
EX-99
awmi89sous8fbqv
31 Oct 14
BioLineRx Reports Publication in Peer Review Journal of
12:00am
6-K
EX-99
jhpid39t8fh 7zo1
21 Jan 14
BioLineRx Receives Approval to Commence
12:00am
6-K
EX-99
ja070cl 4ye6hm0ck
7 Oct 13
BioLineRx Announces Receipt of Notice of Allowance
12:00am
424B3
fr4mt52
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
migq2k4dnudnk
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
6-K
EX-99
0n4ss3ue
30 Apr 13
Current report (foreign)
12:00am
424B3
0m8atnqcpeg j2o
15 Oct 12
Prospectus supplement
12:00am
F-1
jgzi3 6npgs
2 Oct 12
Registration statement (foreign)
12:00am
S-8
EX-3.1
psz6 jn9cd
19 Sep 12
Registration of securities for employees
12:00am
6-K
EX-99
hdh 2w0dw
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am
6-K
EX-99
dob4umd
25 Apr 12
BioLineRx Announces Extension of Patent
12:00am